Advertisement
Advertisement

LEXX

LEXX logo

Lexaria Bioscience Corp. Common Stock

1.03
USD
Sponsored
+0.01
+0.98%
Apr 15, 15:58 UTC -4
Closed
exchange

Pre-Market

1.06

+0.03
+2.91%

Lexaria Bioscience Corp. Common Stock Profile

About

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.

Info & Links

CEO

Richard Christopher

Headquarters

100 - 740 MCCURDY ROAD
KELOWNA, A1 V1X 2P7, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.lexariabioscience.com

Auditor

MaloneBailey, LLP

Share holders

34

Employees

7

Lexaria Bioscience Corp. Common Stock Statistics

Valuation Measures

Market Capitalization2

26.38M

Enterprise Value

21.25M

Enterprise Value/EBITDA(ttm)

-2.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

31.90

Price to Book(mrq)

4.98

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-1685.84%

Profit Margin(ttm)

-1321.57%

Return on Equity(ttm)

-226.58%

Return on Invested Capital(ttm)

-252.50%

Return on Assets(ttm)

-168.35%

Income Statement

Revenue(ttm)

368.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

368.00K

EBITDA(ttm)3

-9.38M

Net Income Available to Common(ttm)

-9.53M

Diluted EPS(ttm)

-0.56

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

-27.97%

S&P 500 52-Week Change

33.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.79M

Dividend Yield

0.00%

Float4

22.80M

% Held by Insiders

8.39%

% Held by Institutions

13.06%

Balance Sheet

Total Cash(mrq)

5.27M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.68%

Quick Ratio(mrq)

3.68%

Book Value Per Share(mrq)

0.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.05

Free Cash Flow(ytd)

-984.10K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement